CLL/SLL IPI-145-12 (#549)
Laufzeit: 01.01.2015 - 31.12.2015
imported
Kurzfassung
A study of IPI-145 and Ofatumumab in patients with chronic
lymphocytic leukemia/small lymphocytic lymphoma previously enrolled in study IPI-145-07 (#548)
